Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options

For the majority of patients with lower-risk myelodysplastic syndrome (LR-MDS), one of the primary clinical goals is to alleviate the symptoms associated with the resultant cytopenias and to minimize the transfusion burden. While supportive red blood cell (RBC) transfusions and erythropoiesis-stimul...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Russell, Bewersdorf, Jan Philipp, Zeidan, Amer M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846829/
https://www.ncbi.nlm.nih.gov/pubmed/33531837
http://dx.doi.org/10.2147/CMAR.S240600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846829/
https://www.ncbi.nlm.nih.gov/pubmed/33531837
http://dx.doi.org/10.2147/CMAR.S240600

Ejemplares similares